My Dashboard
Fin. Planning
Our Solutions
Stocks
Funds
Invest in the best stock opportunities right now and every time.
Start Systematic Stock Investing …in less than a minute.
BSE: 524082 | NSE: | Pharmaceuticals & Drugs | Small Cap
1. Is Harleystreet Pharmaceuticals Ltd. a good quality company?
Data is not available for this company.
2. Is Harleystreet Pharmaceuticals Ltd. undervalued or overvalued?
No data found
3. Is Harleystreet Pharmaceuticals Ltd. a good buy now?
No data found
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
Value Creation ⓘValue Creation Index Colour Code Guide ⓘ |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar'01 | Mar'02 | Mar'03 | Mar'04 | Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | Mar'10 | TTM | |||
| ROCE % ⓘ | 7.5% | 14% | -15.1% | 30.8% | 14% | 23.9% | 19.8% | 11.5% | 12.9% | 16.5% | - | ||
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ |
|||||||||||||
| Sales ⓘ | 2.7 | 1.4 | 0.4 | 0.8 | 0.7 | 0.8 | 1 | 0.9 | 4.5 | 5.7 | 6 | ||
| YoY Gr. Rt. % | - | -49.5% | -74.6% | 114.3% | -4% | 15.3% | 20.5% | -13% | 417.2% | 26.2% | - | ||
| Adj EPS ⓘ | 0.5 | 1 | -1.7 | 4.6 | 2.9 | 6 | 5.5 | 3.2 | 3.6 | 5.6 | 6.5 | ||
| YoY Gr. Rt. % | - | 96.2% | -258.7% | NA | -36.6% | 104.8% | -8.6% | -41.1% | 12.5% | 54.3% | - | ||
| BVPS (₹) ⓘ | 7.1 | 7.2 | 5.7 | 10.3 | 13.3 | 19.2 | 24.7 | 27.9 | 31.6 | 36 | 42.4 | ||
| Adj Net Profit ⓘ | 0.1 | 0.1 | -0.2 | 0.4 | 0.3 | 0.6 | 0.5 | 0.3 | 0.3 | 0.5 | 1 | ||
| Cash Flow from Ops. ⓘ | -0.1 | 0.2 | 1 | 0 | 0.9 | 1.1 | 0.9 | 1.1 | 0.8 | 0.2 | - | ||
| Debt/CF from Ops. ⓘ | -0.3 | 0.2 | 0.5 | -163.7 | 1.7 | 0.7 | 0.8 | 0.4 | 0 | 0 | - | ||
CAGR ⓘCAGR Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9 Years | 5 Years | 3 Years | 1 Years | |||||||||
| Sales ⓘ | 8.5% | 51.2% | 78.4% | 26.2% | ||||||||
| Adj EPS ⓘ | 29.9% | 13.9% | 0.7% | 54.3% | ||||||||
| BVPS ⓘ | 19.8 | 22.1 | 13.4 | 14 | ||||||||
| Share Price | - | - | - | - | ||||||||
Key Financial Parameters ⓘPerformance Ratio Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar'01 | Mar'02 | Mar'03 | Mar'04 | Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | Mar'10 | TTM | ||
| Return on Equity % ⓘ | 7.8 | 14.6 | -25.5 | 57.1 | 24.7 | 36.7 | 24.8 | 12.2 | 12.1 | 16.5 | 16.5 | |
| Op. Profit Mgn % ⓘ | 5.2 | 15.5 | -240.3 | -187.9 | -195.5 | -200.2 | -174.6 | -212.4 | 21.9 | 20.4 | 21.5 | |
| Net Profit Mgn % ⓘ | 1.9 | 7.2 | -44.3 | 58 | 38.6 | 68.3 | 52 | 35 | 7.6 | 9.3 | 9.9 | |
| Debt to Equity ⓘ | 0 | 0 | 0.9 | 1.5 | 1.2 | 0.4 | 0.3 | 0.2 | 0 | 0 | - | |
| Working Cap Days ⓘ | 61 | 81 | 255 | 125 | 167 | 110 | 171 | 270 | 85 | 101 | 0 | |
| Cash Conv. Cycle ⓘ | -15 | 32 | 44 | -37 | 29 | 2 | 27 | 74 | -22 | -7 | 0 | |
No data to display
Return on Equity has declined versus last 3 years average to %
Sales growth has been subdued in last 3 years %
Net Profit has been subdued in last 3 years %
Sales growth is not so good in last 4 quarters at %
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | 6.5 | - |
| TTM Sales (₹ Cr.) | 6.2 | - |
| BVPS (₹.) ⓘ | 42.4 | - |
| Reserves (₹ Cr.) ⓘ | 3 | - |
| P/BV ⓘ | 0.64 | - |
| PE ⓘ | 4.17 | - |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 27.00 / 27.00 |
| All Time Low / High (₹) | 9.98 / 39.95 |
| Market Cap (₹ Cr.) | 2.6 |
| Equity (₹ Cr.) | 1 |
| Face Value (₹) | 10 |
| Industry PE ⓘ | 37.3 |
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Harleystreet Pharmaceuticals Limited was incorporated in1982 and has its registered office at Plot No.142 AB, Kandivli Industrial Estate, Kandivli (West) Mumbai Maharashtra.
Business profile:
The company is engaged in the manufacture and sale of pharmaceuticals in India. It provides formulations of ondansetron. The company offers its products in various forms, including tablets, capsules, liquids, and vials/ampoules.
